In this file
Comparing alternatives to NiceRx is easier when you first identify what needs to change. A first-month discount is useful for cash flow but does not establish ongoing affordability. Compare NiceRx’s continuing figure with the full recurring quote for the prescription and care offered elsewhere.
The provider’s current comparison point is: The ongoing price is higher than the introductory month. The entries below offer different care and payment arrangements to examine against that point.
How to use this shortlist
CoreAge Rx is listed first under a commercial partnership. The first position is predetermined by that relationship, and links may earn compensation. It is not an independent finding that CoreAge has the safest medicine, the lowest total price, or the strongest patient outcomes.
Use NiceRx’s documented arrangement as the baseline, then test the alternatives against the regular cost after enrollment. We compare public care descriptions and payment terms. We have not purchased treatment, audited every professional license, or timed the support response. Use the linked source notes and obtain a current personal quote.
01. CoreAge Rx · sponsored first position
This is the paid featured reference for the question in this guide. Its placement does not establish that every feature discussed here is available through its program. Ask about the exact product and care access before assuming a match.
CoreAge Rx provides an online route to medical assessment and, where a clinician prescribes, pharmacy fulfillment. The service is our paid featured partner. That commercial relationship buys its prominent position here; it does not establish a better medicine, a better outcome, or suitability for any particular reader.
The sale offer shows starting equivalents of $99 for semaglutide and $149 for tirzepatide, without a separate membership charge. Its billing explanation uses a three-month example: $149 per month becomes a single $447 payment. A reader should obtain the duration and total for the selected prescription rather than assuming that the smaller figure is charged monthly.
A question to put to the provider: Can you send the full payment schedule and the name of my dispensing pharmacy before I accept the offer?
Read the CoreAge Rx provider file and cost explanation for the connected details.
02. Brightmeds
The comparison point for Brightmeds: A seasonal three-month promotion differs from the single-month plan.
Brightmeds’ campaign describes provider visits, medication, and delivery within the offer, without a membership fee. Its monthly arrangement is described as automatically renewing.
The Summer Special page lists semaglutide at $297 for three months or $129 for one month; tirzepatide is $357 for three months or $149 for one. The $99 and $119 monthly equivalents belong to the prepaid campaign.
A question to put to the provider: Is the campaign still eligible for my prescription, and at what rate will the plan renew?
The Brightmeds alternatives guide examines this arrangement in more detail. You can also consult the official provider page.
03. Ivy Rx
The comparison point for Ivy Rx: A broad starting offer needs to be tied to a particular GLP-1 plan.
IvyRx describes online medical assessment and delivery after prescribing. It also markets a separate microdosing offer, so different treatment goals and price blocks should not be mixed.
The weight-loss page includes a $77 starting promotion. It does not establish a complete continuing price for every treatment. The FAQ advertises no long contracts or cancellation fees, but the precise prescription and next payment still need confirmation.
A question to put to the provider: Which treatment does the starting figure buy, and what will I pay for its later supply and clinical review?
The Ivy Rx alternatives guide examines this arrangement in more detail. You can also consult the official provider page.
04. OrderlyMeds
The comparison point for OrderlyMeds: A two-month starter package does not establish the maintenance price.
OrderlyMeds distinguishes introductory treatment from continuing care and lists branded pathways separately. Its public process involves screening, provider contact, and pharmacy fulfillment after prescribing. Marketing benefits do not replace the individual medical decision.
The starter offer totals $149 for two months of compounded semaglutide or $299 for two months of compounded tirzepatide. The corresponding averages are $74.50 and $149.50. The page limits starter treatment to eligible patients; these averages should not be carried forward into later refills.
A question to put to the provider: Do I qualify for the starter prescription, and what is the complete first post-starter refill quote?
Read the OrderlyMeds provider file and cost explanation for the connected details.
05. Mochi Health
The comparison point for Mochi Health: Membership and dose-based medication charges must be added together.
Mochi Health organizes care around a recurring membership, with medication purchased separately. Its public explanation of dose-based pricing matters when evaluating older reviews that describe one flat medication charge. A current account quote can differ from those earlier summaries.
The ongoing membership is advertised at $79, with a $39 first-month offer for eligible newcomers. The August 2026 medication explanation lists semaglutide between $60 and $99 and tirzepatide between $90 and $199. Combining the ongoing membership with those ranges gives illustrative totals of $139–$178 and $169–$278, before any additional applicable item.
A question to put to the provider: What will my membership and medication cost together at my prescribed tier, and when is each payment collected?
Read the Mochi Health provider file and cost explanation for the connected details.
06. Pomegranate Health
The comparison point for Pomegranate Health: Facility registration wording does not confer approval on a compounded product.
Pomegranate Health describes online assessment and pharmacy fulfillment. Although supplier descriptions use FDA-related language, the product disclaimer says compounded preparations have not been reviewed or approved by FDA.
Compounded semaglutide is advertised from $119 per month with care and delivery included and no membership charge. Ask which term supports that starting figure and what the later refill will cost.
A question to put to the provider: What is the actual pharmacy’s legal name and state license, and what total applies to my selected term?
The Pomegranate Health alternatives guide examines this arrangement in more detail. You can also consult the official provider page.
Your starting point: NiceRx
NiceRx describes self-pay weight care with provider access, medicine, and shipping included. The page states that insurance is not accepted for this program and that access depends on location and treatment.
Semaglutide is listed at $99 initially and $199 monthly afterward; tirzepatide is $199 initially and $299 thereafter. Use the continuing charge for a recurring budget rather than extending the first-month discount indefinitely.
When must an email cancellation arrive to stop the next order, and has any medication already been dispensed?
Make the decision concrete
Bring these three checks to the shortlist. If an answer describes another product, a different payment period, or a service you are not eligible for, the comparison is not finished.
- Check whether a transfer actually qualifies for any competing introductory treatment package.
- Request the named product, total initial payment, and next renewal in the same written quote.
- Confirm how the receiving clinician reviews existing treatment and how questions are handled between orders.
Separate the product from the provider
FDA approval belongs to a particular drug product, not to a review site’s list or a telehealth brand. A compounded preparation has not received that approval. Ingredient similarity does not establish the same route, formulation, manufacturing controls, or evidence.
Ask the clinician why the exact prescription fits your medical needs. Then ask the pharmacy for the label and instructions appropriate to that product. Read what compounding and FDA approval mean if those terms are being used interchangeably in a promotion.
Before accepting another offer
Keep the current agreement, prescription label, and any pending order information together. A new enrollment does not automatically stop the previous company’s next charge or authorize a continuation prescription.
Use the questions-before-purchase checklist to record the answers in your own words. A useful next step is a clear conversation and a complete proposal, not a decision based on a rank alone.
Source notes
Provider material describes the company’s own offer. Official medical references explain clinical and regulatory context; they do not endorse this publication or its commercial partner.
- CoreAge Rx: official treatment overview ↗Provider-published information · Checked September 22, 2026
- CoreAge Rx: current sale offer ↗Provider-published information · Checked September 22, 2026
- CoreAge Rx: plan billing explained ↗Provider-published information · Checked September 22, 2026
- CoreAge Rx: contact and professional-entity disclosures ↗Provider-published information · Checked September 22, 2026
- CoreAge Rx: purchasing process ↗Provider-published information · Checked September 22, 2026
- Brightmeds: official program, pricing, and care details ↗Provider-published information · Checked September 22, 2026
- Ivy Rx: official program, pricing, and care details ↗Provider-published information · Checked September 22, 2026
- No Insurance GLP-1 and GLP-1/GIP Medication Cost Calculator ↗Provider-published information · Checked September 22, 2026
- Online Medical Weight Loss Program | Mochi Health ↗Provider-published information · Checked September 22, 2026
- Mochi: August 2026 dose-based pricing ↗Provider-published information · Checked September 22, 2026
- Contact us | Mochi Health ↗Provider-published information · Checked September 22, 2026
- Pomegranate Health: official program, pricing, and care details ↗Provider-published information · Checked September 22, 2026
- NiceRx: official program, pricing, and care details ↗Provider-published information · Checked September 22, 2026
- FDA: concerns with unapproved GLP-1 drugs ↗Regulatory / public agency · Checked September 22, 2026
- FDA: risks of compounded drugs ↗Regulatory / public agency · Checked September 22, 2026